TF and cancer: Indeed, several studies have demonstrated that the TF-fVIIa pathway closely correlates with the immune response in cancer tissues [19,20,42,43,44,45,46], as expression of the TF (F3) gene can be augmented by pro-inflammatory transcription factors such as NFκB and AP-1 [10,26].